Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1998
05/07/1998CA2270174A1 Pharmaceutical compositions containing lamivudine and zidovudine
05/07/1998CA2270123A1 Compounds, compositions and methods for treating antibiotic-resistant infections
05/07/1998CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998CA2269663A1 Streptococcus pneumoniae antigens and vaccines
05/07/1998CA2269213A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
05/07/1998CA2268820A1 Stabilized carbapenem antibiotic compositions and method of making
05/07/1998CA2268023A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
05/07/1998CA2265523A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
05/07/1998CA2241626A1 Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae
05/06/1998EP0839910A2 Spo-rel, a Staphylococcus relA/spot homologue
05/06/1998EP0839830A1 Polyether nucleic acids
05/06/1998EP0839827A1 Novel polyhydro derivatives of tylosine and process for their preparation
05/06/1998EP0839798A2 Intermediates for preparating non-peptide retroviral protease inhibitors
05/06/1998EP0839529A2 Compositions containing aliphatic monocarboxylic acid esters or amides for the treatment of skin diseases
05/06/1998EP0839206A1 Cd4 gene regulatory sequences specifically expressed in mature t cells
05/06/1998EP0839156A1 Anti-fungal peptides
05/06/1998EP0839050A1 Method of enhancing cell mediated immune responses
05/06/1998EP0839046A1 Tnf receptor and steroid hormone in a combined therapy
05/06/1998EP0839042A1 Bacterial inhibition with an oligosaccharide compound
05/06/1998EP0839035A2 Antifungal agent, compound therefor, process for producing the same
05/06/1998EP0839033A2 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral
05/06/1998EP0839026A1 Polyether block copolymer micellar compositions for targeting biological agents
05/06/1998EP0788364A4 Treatment of urogenital cancer with boron neutron capture therapy
05/06/1998EP0742790A4 Substituted purines and oligonucleotide cross-linking
05/06/1998EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors
05/06/1998CN1181075A Substituted isoxazoles for the treatment of inflammation
05/06/1998CN1181066A Arylsulfonylamino hydroxamic acid derivatives
05/06/1998CN1181018A 多功能酶 Multifunctional enzyme
05/06/1998CN1181013A Anti-virus triaza compounds
05/06/1998CN1181010A A Pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
05/06/1998CN1181009A A Pharmaceutical composition N-chlorophenylcarbamates, N-chlorophenylthiocarbamates and N-phosphonoglycine derwatives for inhibiting the growth of cancers and viruses in mammals
05/06/1998CN1180698A Substituted dismino -1, 3, 5-triazine derivatives
05/06/1998CN1180568A Hepatitis B virus converting negative tablet
05/05/1998US5747639 Use of hydrophobic interaction chromatography to purify polyethylene glycols
05/05/1998US5747511 Treatment of herpes infections
05/05/1998US5747500 Antiviral 2, 4-pyrimidinedione derivatives
05/05/1998US5747488 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection
05/05/1998US5747484 Bactericides
05/05/1998US5747483 Antibiotics and bactericides
05/05/1998US5747473 L-nucleoside analogues and pharmaceutical compositions
05/05/1998US5747467 Erythromycins
05/05/1998US5747465 Sugar derivatives of macrolides
05/05/1998US5747315 DNA encoding aspartyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747314 Nucleotides and genetic vectors
05/05/1998US5747313 DNA encoding histidyl tRNA synthetase from Streptococcus pneumoniae
05/05/1998US5747295 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T
05/05/1998US5747286 Polynucleotides encoding a transcriptional response regulator of Streptococcus pneumoniae
05/05/1998US5747044 Hepatitis delta diagnostics and vaccines
05/05/1998US5746996 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
05/05/1998CA2152588C Anti-androgenic cyclo and bicyclo alkenes
05/05/1998CA2097589C Targeting of therapeutic agents using polysaccharides
05/05/1998CA1339857C Monoclonal antibodies to gp120 which neutraleze hiv-1
05/05/1998CA1339854C Viral treatment system
04/1998
04/30/1998WO1998017820A1 Vaccines
04/30/1998WO1998017810A2 Multi-functional chimeric hematopoietic receptor agonists
04/30/1998WO1998017799A1 Immunotherapy and improved vaccines
04/30/1998WO1998017779A1 NOVEL FabH
04/30/1998WO1998017685A1 Novel lanthionine antibiotic compositions and methods
04/30/1998WO1998017647A1 Piperidine compounds
04/30/1998WO1998017639A1 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
04/30/1998WO1998017321A1 Gene delivery and expression in areas inaccessible to direct protein delivery
04/30/1998WO1998017313A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
04/30/1998WO1998017309A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection
04/30/1998WO1998017303A1 A method for the treatment of streptococcus pneumoniae infection
04/30/1998WO1998017302A1 Total synthesis of the amino hip analogue of didemnin a
04/30/1998WO1998017301A1 Peptides for inhibiting retroviruses
04/30/1998WO1998017294A1 Pharmaceutical and cosmetic formulations with antimicrobial activity
04/30/1998WO1998017293A1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea)
04/30/1998WO1998017289A1 Therapeutic use of hemoglobin to treat head injury
04/30/1998WO1998017279A1 Immune response modifier compounds for treatment of th2 mediated and related diseases
04/30/1998WO1998017275A1 Semi-synthetic studies toward didemnin analogues
04/30/1998WO1998017272A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
04/30/1998WO1998017214A1 Method for treating dementia due to aids
04/30/1998WO1998017116A1 Targeted cytotoxic cells
04/30/1998WO1998004694A3 Secreted proteins and polynucleotides encoding them
04/30/1998CA2751712A1 Immunotherapy and improved vaccines
04/30/1998CA2745736A1 Immunotherapy and improved vaccines
04/30/1998CA2272601A1 Peptides for inhibiting retroviruses
04/30/1998CA2269881A1 Semi-synthetic studies toward didemnin analogues
04/30/1998CA2269878A1 Total synthesis of the amino hip analogue of didemnin a
04/30/1998CA2269825A1 Gene delivery and expression in areas inaccessible to direct protein delivery
04/30/1998CA2269754A1 Dna vaccines for herpes simplex virus 1 and 2
04/30/1998CA2269614A1 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
04/30/1998CA2269533A1 Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
04/30/1998CA2269507A1 Targeted cytotoxic cells
04/30/1998CA2269506A1 Method for treating dementia due to aids
04/30/1998CA2269074A1 Immunotherapy and improved vaccines
04/30/1998CA2268930A1 Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
04/30/1998CA2268756A1 Piperidine compounds
04/30/1998CA2268744A1 Novel lanthionine antibiotic compositions and methods
04/30/1998CA2268742A1 Multi-functional chimeric hematopoietic receptor agonists
04/30/1998CA2268720A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection
04/30/1998CA2268517A1 Therapeutic use of hemoglobin to treat head injury
04/30/1998CA2264794A1 A method for the treatment of streptococcus pneumoniae infection
04/30/1998CA2217785A1 Novel polyhydro derivatives of tylosine and process for their preparation
04/29/1998EP0838470A1 9-N-ethenyl derivatives of 9(S)-erythromycylamine
04/29/1998EP0838453A1 Heterocyclic carboxylic acid derivatives and drugs containing the same
04/29/1998EP0838222A1 Vaccine compositions comprising inactivated immunogens and live chicken anaemia virus (CAV)
04/29/1998EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque
04/29/1998EP0837952A2 Detection and quantification of human herpesvirus 7 by enzymatic amplification of virus dna
1 ... 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 ... 1798